These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23108408)

  • 1. miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.
    Kliese N; Gobrecht P; Pachow D; Andrae N; Wilisch-Neumann A; Kirches E; Riek-Burchardt M; Angenstein F; Reifenberger G; Riemenschneider MJ; Meese E; Panayotova-Dimitrova D; Gutmann DH; Mawrin C
    Oncogene; 2013 Sep; 32(39):4712-20. PubMed ID: 23108408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of S6K overexpression in meningioma progression.
    Surace EI; Lusis E; Haipek CA; Gutmann DH
    Ann Neurol; 2004 Aug; 56(2):295-8. PubMed ID: 15293284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-195 Functions as a Tumor Suppressor by Directly Targeting Fatty Acid Synthase in Malignant Meningioma.
    Song LR; Li D; Weng JC; Li CB; Wang L; Wu Z; Zhang JT
    World Neurosurg; 2020 Apr; 136():e355-e364. PubMed ID: 31927122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas.
    Tang H; Zhu H; Wang X; Hua L; Li J; Xie Q; Chen X; Zhang T; Gong Y
    J Mol Cell Biol; 2017 Aug; 9(4):315-324. PubMed ID: 28651379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of disabled-2 is common reduced in meningiomas.
    Zhang Z; Chen Y; Xie X; Tang J
    Neurol India; 2014; 62(1):57-61. PubMed ID: 24608456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA expression signature predicts meningioma recurrence.
    Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
    Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.
    Utsuki S; Oka H; Sato Y; Kawano N; Tsuchiya B; Kobayashi I; Fujii K
    Clin Neuropathol; 2005; 24(1):8-12. PubMed ID: 15696778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
    McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
    J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
    Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
    Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.
    Kondraganti S; Gondi CS; Gujrati M; McCutcheon I; Dinh DH; Rao JS; Olivero WC
    Int J Oncol; 2006 Jul; 29(1):25-32. PubMed ID: 16773181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
    Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
    Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
    Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
    Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
    J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.